Search Results - "Safont, M. José"

Current controversies in the management of metastatic colorectal cancer by Vera, Ruth, Alonso, Vicente, Gállego, Javier, González, Encarnación, Guillén-Ponce, Carmen, Pericay, Carles, Rivera, Fernando, Safont, Mª José, Valladares-Ayerbes, Manuel

“…The factors affecting the decisions for the treatment for patients with metastatic colorectal cancer (mCRC) are related to the patient, the tumor, and the…”
Get full text

Neoadjuvant capecitabine, oxliplatin, and bevacizumab (CAPOX-B) in intermediate-risk rectal cancer (RC) patients defined by magnetic resonance (MR): GEMCAD 0801 trial by Fernandez-Martos, Carlos, Estevan, Rafael, Salud, Antonia, Pericay, Carles, Gallen, Manuel, Sierra, Enrique, Serra, Javier, Pera, Miguel, Maurel, Juan, Delgado, Salvadora, Safont, M. José, Roig, Jose Vicente, Aparicio, Jorge, Feliu, Jaime, Garcia, Damian, Vera, Ruth, Suarez, Javier, Alonso, Vicente, Martin-Richard, Marta, Brown, Gina

“…Abstract only 3586 Background: Retrospective data suggest that RT might not be needed in all patients with stage II/III RC. Modern systemic therapy might have…”
Get full text

Current Options for Third-line and Beyond Treatment of Metastatic Colorectal Cancer. Spanish TTD Group Expert Opinion by Fernández-Montes, Ana, Grávalos, Cristina, Pericay, Carles, Safont, Ma José, Benavides, Manuel, Élez, Elena, García-Alfonso, Pilar, García-Paredes, Beatriz, Carrato, Alfredo, Aranda, Enrique

“…Colorectal cancer (CRC) is a public health problem: it is the third most common cancer in men (746,000 new cases/year) and the second in women (614,000 new…”
Get full text

Self-evaluation of a clinical pathway to improve the results of rectal cancer by Sancho, Cristina, Villalba, Francisco L, García-Coret, M José, Vázquez, Antonio, Safont, M José, Hernández, Ana, Martínez, Encarnación, Martínez-Sanjuán, Vicente, García-Armengol, Juan, Roig, José V

“…To analyse whether the self-evaluation of a clinical pathway improves the results of rectal cancer (RC) treatment. Patients operated on for RC were divided…”
Get more information

Self-evaluation of a clinical pathway to improve the results of rectal cancer by Sancho, Cristina, Villalba, Francisco L, José García-Coret, M, Vázquez, Antonio, José Safont, M, Hernández, Ana, Martínez, Encarnación, Martínez-Sanjuán, Vicente, García-Armengol, Juan, Roig, José V

“…Abstract Objectives To analyse whether the self-evaluation of a clinical pathway improves the results of rectal cancer (RC) treatment. Patients and method…”
Get full text

Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a TTD group cooperative study by Díaz-Rubio, Eduardo, Gómez-España, Auxiliadora, Massutí, Bartomeu, Sastre, Javier, Reboredo, Margarita, Manzano, José Luis, Rivera, Fernando, Safont, M José, Montagut, Clara, González, Encarnación, Benavides, Manuel, Marcuello, Eugenio, Cervantes, Andrés, Martínez de Prado, Purificación, Fernández-Martos, Carlos, Arrivi, Antonio, Bando, Inmaculada, Aranda, Enrique

“…In the MACRO study, patients with metastatic colorectal cancer (mCRC) were randomised to first-line treatment with 6 cycles of capecitabine and oxaliplatin…”
Get full text

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer by Martinez Villacampa, Mercedes, Capdevila, Jaume, Manzano, Jose Luis, Pericay, Carles, Salazar, Ramon, López-López, Carlos, Losa, Ferran, Safont, M. José, Gomez, Auxiliadora, Alonso, Vicente, Escudero, M. Pilar, Gallego Plazas, Javier, Sastre, Javier, Gravalos Castro, Cristina, Biondo, Sebastiano, Palacios, Amalia, Aranda, Enrique

“…Abstract only 3571 Background: The addition of bevacizumab (BEV) to capecitabine (CAP)-based chemoradiation (CRT) has shown encouraging efficacy in locally…”
Get full text

Comparison of magnetic resonance imaging and histopathological response to neoadjuvant chemotherapy in locally advanced rectal cancer: The GEMCAD 0801 trial by Brown, Gina, Patel, Uday Bharat, Santos Cores, Jesus, Isabel Gil Garcia, Maria, Ayuso, Juan Ramón, Puchades Roman, Iciar, Mas Estelles, Fernando, Risueno, Noelia, Salud, Antonieta, Maurel, Juan, Aparicio, Jorge, Pericay Pijaume, Carles, Alonso, Vicente, Safont, M. José, Gallén, Manuel, Vera, Ruth, Feliu, Jaime, Martin-Richard, Marta, Fernandez-Martos, Carlos

“…Abstract only e14097 Background: MRI methods for rectal cancer response assessment post chemoradiotherapy include post treatment T staging(ymrT), tumor…”
Get full text

Incidence of hand–foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen by Gómez-Martin, Carlos, Sánchez, Antonio, Irigoyen, Antonio, Llorente, Beatriz, Pérez, Begoña, Serrano, Raquel, Safont, Mª José, Falcó, Esther, Lacasta, Adelaida, Reboredo, Margarita, Aparicio, Jorge, Dueñas, Rosario, Muñoz, Marta Llanos, Regueiro, Pilar, Sanchez-Viñes, Elena, López, Rafael López

“…Introduction Hand–foot syndrome (HFS) is a limiting toxicity of capecitabine, which is not life-threatening but could compromise capecitabine efficacy…”
Get full text